Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Glenmark Life Sciences Ltd is a manufacturer of pharmaceutical preparation. The Company was founded in June 2011 and is located in Solapur, India.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
3 weeks ago•Economic Times
3 weeks ago•Business Standard
1 month ago•The Hindu Businessline
Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated July 25, 2024, titled "Press Release on the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2024". | Download
Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated July 25, 2024, titled "Press Release on the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2024". | Download
Interim • Div/Share: ₹ 22.5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant